# Single-cell multi-omics reveal stage of differentiation and trajectory-dependent immunity-related gene expression patterns in human erythroid cells

**Authors:** Roman Perik-Zavodskii, Olga Perik-Zavodskaia, Saleh Alrhmoun, Marina Volynets, Julia Shevchenko, Kirill Nazarov, Vera Denisova, Sergey Sennikov

PMC · DOI: 10.3389/fimmu.2024.1431303 · 2024-08-29

## TL;DR

This study uses single-cell techniques to uncover how human bone marrow erythroid cells express immunity-related genes during their development and in leukemia.

## Contribution

The study reveals novel gene expression patterns in erythroid cells, including immunosuppressive and cytokine genes, and their changes in leukemia.

## Key findings

- Human bone marrow erythroid cells express ARG1, LGALS1, LGALS3, LGALS9, and VISTA immunosuppressive genes.
- ARG1 gene expression is specific to a cluster of orthochromatic erythroblasts.
- Late erythroid cells in leukemia lose S100A9 and gain MZB1 gene expression.

## Abstract

The role of Erythroid cells in immune regulation and immunosuppression is one of the emerging topics in modern immunology that still requires further clarification as Erythroid cells from different tissues and different species express different immunoregulatory molecules. In this study, we performed a thorough investigation of human bone marrow Erythroid cells from adult healthy donors and adult acute lymphoblastic leukemia patients using the state-of-the-art single-cell targeted proteomics and transcriptomics via BD Rhapsody and cancer-related gene copy number variation analysis via NanoString Sprint Profiler. We found that human bone marrow Erythroid cells express the ARG1, LGALS1, LGALS3, LGALS9, and C10orf54 (VISTA) immunosuppressive genes, CXCL5, CXCL8, and VEGFA cytokine genes, as well as the genes involved in antimicrobial immunity and MHC Class II antigen presentation. We also found that ARG1 gene expression was restricted to the single erythroid cell cluster that we termed ARG1-positive Orthochromatic erythroblasts and that late Erythroid cells lose S100A9 and gain MZB1 gene expression in case of acute lymphoblastic leukemia. These findings show that steady-state erythropoiesis bone marrow Erythroid cells express myeloid signature genes even without any transdifferentiating stimulus like cancer.

## Linked entities

- **Genes:** ARG1 (arginase 1) [NCBI Gene 383], LGALS1 (galectin 1) [NCBI Gene 3956], LGALS3 (galectin 3) [NCBI Gene 3958], LGALS9 (galectin 9) [NCBI Gene 3965], VSIR (V-set immunoregulatory receptor) [NCBI Gene 64115], VSIR (V-set immunoregulatory receptor) [NCBI Gene 64115], CXCL5 (C-X-C motif chemokine ligand 5) [NCBI Gene 6374], CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422], S100A9 (S100 calcium binding protein A9) [NCBI Gene 6280], MZB1 (marginal zone B and B1 cell specific protein) [NCBI Gene 51237]
- **Diseases:** acute lymphoblastic leukemia (MONDO:0004967)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** S100A9 (S100 calcium binding protein A9) [NCBI Gene 6280] {aka 60B8AG, CAGB, CFAG, CGLB, L1AG, LIAG}, VSIR (V-set immunoregulatory receptor) [NCBI Gene 64115] {aka B7-H5, B7H5, C10orf54, DD1alpha, Dies1, GI24}, CXCL5 (C-X-C motif chemokine ligand 5) [NCBI Gene 6374] {aka ENA-78, SCYB5}, LGALS3 (galectin 3) [NCBI Gene 3958] {aka CBP35, GAL3, GALBP, GALIG, L31, LGALS2}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, LGALS1 (galectin 1) [NCBI Gene 3956] {aka GAL1, GBP}, LGALS9 (galectin 9) [NCBI Gene 3965] {aka HUAT, LGALS9A}, MZB1 (marginal zone B and B1 cell specific protein) [NCBI Gene 51237] {aka MEDA-7, PACAP, pERp1}, ARG1 (arginase 1) [NCBI Gene 383], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}
- **Diseases:** cancer (MESH:D009369), acute lymphoblastic leukemia (MESH:D054198)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11390661/full.md

---
Source: https://tomesphere.com/paper/PMC11390661